Press Announcements
Note: Press announcements from 2004 to 2015 are available through the FDA.gov Archive. Some links in press announcements may no longer be active. For more information, contact FDA’s Office of Media Affairs at 301-796-4540.
Sign up to receive FDA Press Releases.
April 2018
- April 20, 2018 - FDA authorizes new use of test, first to identify the emerging pathogen Candida auris
- April 20, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on new steps to encourage more widespread innovation and development of new treatments for opioid use disorder
- April 20, 2018 - FDA takes new steps to advance the development of innovative products for treating opioid use disorder
- April 19, 2018 - Federal judge enters consent decree against Cantrell Drug Company
- April 17, 2018 - Remarks from FDA Commissioner Scott Gottlieb, M.D. on Fiscal Year 2019 budget request for FDA
- April 17, 2018 - FDA approves first therapy for rare inherited form of rickets, x-linked hypophosphatemia
- April 17, 2018 - Statement by Dr. Susan Mayne on FDA efforts to reduce consumer exposure to arsenic in rice
- April 17, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to enhance and modernize the FDA’s approach to medical device safety and innovation
- April 13, 2018 - La FDA toma medidas para proteger a los consumidores de los suplementos alimenticios que contienen niveles peligrosamente altos de cafeína altamente concentrada o pura
- April 13, 2018 - FDA takes step to protect consumers against dietary supplements containing dangerously high levels of extremely concentrated or pure caffeine
- April 12, 2018 - FDA finalizes guidances to accelerate the development of reliable, beneficial next generation sequencing-based tests
- April 11, 2018 - FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems
- April 10, 2018 - FDA clears first contact lens with light-adaptive technology
- April 09, 2018 - FDA restricts sale and distribution of Essure to protect women and to require that patients receive risk information
- April 03, 2018 - FDA orders mandatory recall for kratom products due to risk of salmonella
- April 02, 2018 - New York raw milk cheese company ordered to stop sales for food safety violations
March 2018
- March 30, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s efforts to enhance the patient perspective and experience in drug development and review
- March 29, 2018 - FDA expands approval of Blincyto for treatment of a type of leukemia in patients who have a certain risk factor for relapse
- March 29, 2018 - Federal judge approves consent decree with New York dietary supplement manufacturer Riddhi USA
- March 28, 2018 - Federal judge approves consent decree with Florida company that sold unapproved new drugs and misbranded drugs
- March 27, 2018 - FDA authorizes first fully interoperable continuous glucose monitoring system, streamlines review pathway for similar devices
- March 23, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on a key step in advancing FDA’s oversight of drug compounding and implementing new laws governing outsourcing facilities
- March 22, 2018 - Statement from FDA’s Donald St. Pierre on findings from ongoing investigation into lead testing issues
- March 20, 2018 - FDA expands approval of Adcetris for first-line treatment of Stage III or IV classical Hodgkin lymphoma in combination with chemotherapy
- March 20, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to reduce tobacco use, especially among youth, by exploring options to address the role of flavors ‒ including menthol ‒ in tobacco products
- March 15, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on pivotal public health step to dramatically reduce smoking rates by lowering nicotine in combustible cigarettes to minimally or non-addictive levels
- March 09, 2018 - FDA warns duodenoscope manufacturers about failure to comply with required postmarket surveillance studies to assess contamination risk
- March 08, 2018 - Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for oral testimony before the U.S. House Committee on Energy and Commerce Subcommittee on Oversight and Investigations hearing “Examining U.S. Public Health Preparedness for and Response Efforts to Seasonal Influenza.”
- March 08, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on effort to help bolster U.S. shellfish market by taking mutually beneficial steps to resume shellfish trade with the EU
- March 07, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA activities related to the ongoing post-market review of Essure and FDA’s commitment to keep women informed
- March 06, 2018 - FDA approves first tests to screen for tickborne parasite in whole blood and plasma to protect the U.S. blood supply
- March 06, 2018 - FDA expands approval of replacement heart valve, smallest mechanical valve size approved in the world
- March 06, 2018 - FDA approves new HIV treatment for patients who have limited treatment options
- March 06, 2018 - FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes
- March 05, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s commitment to modernizing food and nutrition programs
- March 02, 2018 - FDA warns of fraudulent and unapproved flu products
- March 01, 2018 - FDA alerts health care professionals and patients not to use compounded drugs from Cantrell Drug Company; agency seeks action to stop production and distribution
- March 01, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new efforts to advance implementation of the new consumer Nutrition Facts label for foods
February 2018
- February 26, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s ongoing efforts to help improve effectiveness of influenza vaccines
- February 23, 2018 - Statement from Stephen Ostroff M.D., Deputy Commissioner for Foods and Veterinary Medicine, on National Toxicology Program draft report on Bisphenol A
- February 21, 2018 - FDA oversees destruction and recall of kratom products; and reiterates its concerns on risks associated with this opioid
- February 16, 2018 - FDA expands approval of Imfinzi to reduce the risk of non-small cell lung cancer progressing
- February 15, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D. on the efficacy of the 2017-2018 influenza vaccine
- February 15, 2018 - FDA expands treatment window for use of clot retrieval devices in certain stroke patients
- February 15, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D. on advancing the development of novel treatments for neurological conditions; part of broader effort on modernizing FDA’s new drug review programs
- February 14, 2018 - FDA approves new treatment for a certain type of prostate cancer using novel clinical trial endpoint
- February 14, 2018 - FDA authorizes marketing of first blood test to aid in the evaluation of concussion in adults
- February 13, 2018 - FDA permits marketing of clinical decision support software for alerting providers of a potential stroke in patients
- February 13, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on Administration’s request for new FDA funding to promote innovation and broaden patient access through competition
- February 08, 2018 - Statement from FDA Commissioner Scott Gottlieb, M.D., on groundbreaking approval and interagency approach to bring stable supply of critical medical imaging isotope to the U.S.